Novo Nordisk initiates its share repurchase programme

On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 2.4 billion in the period from 10 August 2009 to 18 December 2009.

Since the announcement as of 28 September 2009, the following transactions have been made under the programme:

Number of Average Transaction shares purchase price value, DKK Accumulated, last announcement 2,682,500 853,849,597 28 September 2009 70,000 320.8900 22,462,300 29 September 2009 59,500 321.9410 19,155,490 30 September 2009 75,000 318.8990 23,917,425 1 October 2009 75,000 317.6710 23,825,325 2 October 2009 70,000 319.9301 22,395,107 Accumulated under the programme 3,032,000 965,605,244

With the transactions stated above, Novo Nordisk owns a total of 27,868,808 treasury shares, corresponding to 4.5% of the share capital. The total amount of shares in the company is 620,000,000 including treasury shares.

Correction:

In the company announcement as of 28 September 2009 related to the share repurchase programme, the dates in the table were not updated properly. All numbers and ownership figures were however correct.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Novo Nordisk. (2019, June 19). Novo Nordisk initiates its share repurchase programme. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/news/20091005/Novo-Nordisk-initiates-its-share-repurchase-programme.aspx.

  • MLA

    Novo Nordisk. "Novo Nordisk initiates its share repurchase programme". News-Medical. 31 October 2024. <https://www.news-medical.net/news/20091005/Novo-Nordisk-initiates-its-share-repurchase-programme.aspx>.

  • Chicago

    Novo Nordisk. "Novo Nordisk initiates its share repurchase programme". News-Medical. https://www.news-medical.net/news/20091005/Novo-Nordisk-initiates-its-share-repurchase-programme.aspx. (accessed October 31, 2024).

  • Harvard

    Novo Nordisk. 2019. Novo Nordisk initiates its share repurchase programme. News-Medical, viewed 31 October 2024, https://www.news-medical.net/news/20091005/Novo-Nordisk-initiates-its-share-repurchase-programme.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
RetiPharma secures funding to develop new peptide drug for treating degenerative eye disorders